ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,227, issued on Feb. 18, was assigned to The University of Chicago (Chicago).
"Neurophysiological biomarkers for neurodegenerative disorders" was invented by Naoum P. Issa (Chicago) and Kourosh Rezania (Chicago).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for diagnosing and determining the disease progression of neurodegenerative disorders in patients using neurophysiological biomarkers."
The patent was filed on Nov. 28, 2022, under Application No. 17/994,969.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=...